Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renuka V Iyer

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Cancers|July 30, 2020
Hepatocellular Carcinoma: Special Issue HighlightsMedhavi Gupta, Renuka V Iyer
Cancers|June 10, 2022
Updates in Biliary Tract CancersDaneng Li, Ya-Han Zhang, Christiana J Crook, et al.
Pharmacotherapy|September 17, 2013
Carboplatin pharmacokinetics in a patient receiving hemodialysisMei Ka Fong, Gerald J Fetterly, Lori J McDougald, et al.
Cancer Chemotherapy and Pharmacology|January 1, 2009
Rituximab-based therapy for gemcitabine-induced hemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma: a case reportAnubha Bharthuar, Lori Egloff, Joanne Becker, et al.
Annals of Surgical Oncology|August 21, 2007
A phase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and carcinoma of the gallbladder: a single-institution prospective studyRenuka V Iyer, John Gibbs, Boris Kuvshinoff, et al.
Thrombosis Research|July 17, 2013
Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancersAnubha Bharthuar, Alok A Khorana, Alan Hutson, et al.
Journal of Gastrointestinal Oncology|November 16, 2023
Evaluation of the serotonin pathway as a biomarker in cholangiocarcinomaChristos Fountzilas, Sylvia Alarcon Velasco, Wiam Bshara, et al.
American Journal of Clinical Oncology|November 17, 2016
A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumab for Locally Advanced or Metastatic Biliary Tract CancerRenuka V Iyer, Venkata K Pokuri, Adrienne Groman, et al.
Anti-Cancer Drugs|July 3, 2008
Scheduled administration of low dose irinotecan before gemcitabine in the second line therapy of non-small cell lung cancer: a phase II studyNithya Ramnath, Jihnhee Yu, Nikhil I Khushalani, et al.
The Journal of Surgical Research|March 7, 2020
A Translational Hepatic Artery Infusion (HAI) Model for Hepatocellular Carcinoma in WoodchucksMinhyung Kim, Colin A Powers, Leslie I Curtin, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Cancers|July 30, 2020
Hepatocellular Carcinoma: Special Issue HighlightsMedhavi Gupta, Renuka V Iyer
Cancers|June 10, 2022
Updates in Biliary Tract CancersDaneng Li, Ya-Han Zhang, Christiana J Crook, et al.
Pharmacotherapy|September 17, 2013
Carboplatin pharmacokinetics in a patient receiving hemodialysisMei Ka Fong, Gerald J Fetterly, Lori J McDougald, et al.
Cancer Chemotherapy and Pharmacology|January 1, 2009
Rituximab-based therapy for gemcitabine-induced hemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma: a case reportAnubha Bharthuar, Lori Egloff, Joanne Becker, et al.
Annals of Surgical Oncology|August 21, 2007
A phase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and carcinoma of the gallbladder: a single-institution prospective studyRenuka V Iyer, John Gibbs, Boris Kuvshinoff, et al.
Thrombosis Research|July 17, 2013
Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancersAnubha Bharthuar, Alok A Khorana, Alan Hutson, et al.
Journal of Gastrointestinal Oncology|November 16, 2023
Evaluation of the serotonin pathway as a biomarker in cholangiocarcinomaChristos Fountzilas, Sylvia Alarcon Velasco, Wiam Bshara, et al.
American Journal of Clinical Oncology|November 17, 2016
A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumab for Locally Advanced or Metastatic Biliary Tract CancerRenuka V Iyer, Venkata K Pokuri, Adrienne Groman, et al.
Anti-Cancer Drugs|July 3, 2008
Scheduled administration of low dose irinotecan before gemcitabine in the second line therapy of non-small cell lung cancer: a phase II studyNithya Ramnath, Jihnhee Yu, Nikhil I Khushalani, et al.
The Journal of Surgical Research|March 7, 2020
A Translational Hepatic Artery Infusion (HAI) Model for Hepatocellular Carcinoma in WoodchucksMinhyung Kim, Colin A Powers, Leslie I Curtin, et al.
Pageof 3